Ulvestad E - Search Results

1

Myrmel H, Ulvestad E, Asjø B. Myrmel H, et al. Among authors: ulvestad e. APMIS. 2009 May;117(5-6):427-39. doi: 10.1111/j.1600-0463.2009.02454.x. APMIS. 2009. PMID: 19400866 Review.

2

Performance characteristics of a glycoprotein G based oligopeptide (peptide 55) and two different methods using the complete glycoprotein as assays for detection of anti-HSV-2 antibodies in human sera.

Nilsen A, Ulvestad E, Marsden H, Langeland N, Myrmel H, Matre R, Haarr L. Nilsen A, et al. Among authors: ulvestad e. J Virol Methods. 2003 Jan;107(1):21-7. doi: 10.1016/s0166-0934(02)00185-4. J Virol Methods. 2003. PMID: 12445934

3

[HIV-1 resistance against antiretroviral agents].

Asjø B, Ulvestad E. Asjø B, et al. Among authors: ulvestad e. Tidsskr Nor Laegeforen. 2001 Nov 30;121(29):3421-4. Tidsskr Nor Laegeforen. 2001. PMID: 11826790 Free article. Norwegian.

4

Population-based hematologic and immunologic reference values for a healthy Ugandan population.

Lugada ES, Mermin J, Kaharuza F, Ulvestad E, Were W, Langeland N, Asjo B, Malamba S, Downing R. Lugada ES, et al. Among authors: ulvestad e. Clin Diagn Lab Immunol. 2004 Jan;11(1):29-34. doi: 10.1128/cdli.11.1.29-34.2004. Clin Diagn Lab Immunol. 2004. PMID: 14715541 Free PMC article.

5

Changes in immunoglobulin isotypes and immunoglobulin G (IgG) subclasses during highly active antiretroviral therapy: anti-p24 IgG1 closely parallels the biphasic decline in plasma viremia.

Voltersvik P, Albrektsen G, Ulvestad E, Dyrhol-Riise AM, Sørensen B, Asjö B. Voltersvik P, et al. Among authors: ulvestad e. J Acquir Immune Defic Syndr. 2003 Dec 1;34(4):358-67. doi: 10.1097/00126334-200312010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 14615653

6

Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway.

Lugada ES, Mermin J, Asjo B, Kaharuza F, Downing R, Langeland N, Ormaasen V, Bruun J, Awor AC, Ulvestad E. Lugada ES, et al. Among authors: ulvestad e. Scand J Immunol. 2004 Feb;59(2):203-8. doi: 10.1111/j.0300-9475.2004.01376.x. Scand J Immunol. 2004. PMID: 14871298 Free article.

7

Host-microbe relations.

Ulvestad E, Thomsen AR. Ulvestad E, et al. APMIS. 2009 May;117(5-6):309-10. doi: 10.1111/j.1600-0463.2009.02455.x. APMIS. 2009. PMID: 19400858 No abstract available.

8

Cooperation and conflict in host-microbe relations.

Ulvestad E. Ulvestad E. APMIS. 2009 May;117(5-6):311-22. doi: 10.1111/j.1600-0463.2009.02457.x. APMIS. 2009. PMID: 19400859 Review.

9

Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.

Aarstad HJ, Vintermyr OK, Ulvestad E, Aarstad HH, Kross KW, Heimdal JH. Aarstad HJ, et al. Among authors: ulvestad e. APMIS. 2015 Apr;123(4):305-14. doi: 10.1111/apm.12356. APMIS. 2015. PMID: 25801083

10

Inhibition of phytohaemagglutinin-induced lymphoproliferation by soluble annexin II in sera from patients with renal cell carcinoma.

Aarli A, Skeie Jensen T, Kristoffersen EK, Bakke A, Ulvestad E. Aarli A, et al. Among authors: ulvestad e. APMIS. 1997 Sep;105(9):699-704. doi: 10.1111/j.1699-0463.1997.tb05073.x. APMIS. 1997. PMID: 9350213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters